Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

St. Jude Medical Acquires Endosense - Quick Facts

RELATED NEWS
Trade STJ now with 
8/19/2013 8:08 AM ET

St. Jude Medical Inc. (STJ: Quote) announced the acquisition of Endosense SA, a Switzerland-based medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias. St. Jude Medical has made an initial payment of approximately $170 million, and acquired 100 percent of the outstanding equity of Endosense. The terms also provide for an additional cash payment of up to $161 million, which is contingent upon both the achievement and timing of a regulatory milestone.

St. Jude Medical said, except for acquisition-related expenses, the deal does not impact its outlook for 2013 consolidated earnings per share.

Click here to receive FREE breaking news email alerts for St. Jude Medical Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Restaurant operator Yum! Brands Inc. said Tuesday after the markets closed that its first quarter profit rose 18% from last year, helped by strong performance of its China division. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast. After trending higher over the past several sessions, stocks saw some further upside during trading on Tuesday. A positive reaction to the latest corporate news contributed to the continued buying interest, lifting the Dow and the S&P 500 back near their record highs. In a blow to supporters of affirmative action, the Supreme Court on Tuesday upheld a voter-approved ban on using race as a factor in college admissions at Michigan's state-run universities. The court ruled 6 to 2 that the state law banning the use of racial preferences does not violate the U.S. Constitution, although the court was splintered on the reasoning for the decision.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.